Endo Pharmaceuticals competitive analysis

Explore Endo Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Apr 15, 2015Compositions And Methods For Treating Central Precocious Puberty1

Latest PTAB cases involving Endo Pharmaceuticals

Discover the latest PTAB cases involving Endo Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 29, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Endo Pharmaceuticals

IPR2014-01365Aug 22, 2014AMNEAL PHARMACEUTICALSENDO PHARMACEUTICALSFinal Written Decision
IPR2014-00360Jan 16, 2014AMNEAL PHARMACEUTICALSENDO PHARMACEUTICALSFinal Written Decision
IPR2014-00361Jan 16, 2014AMNEAL PHARMACEUTICALSENDO PHARMACEUTICALSInstitution Denied
IPR2014-00160Nov 18, 2013AMNEAL PHARMACEUTICALSENDO PHARMACEUTICALSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Endo Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ENDO PHARMACEUTICALS - - - 4
AMNEAL PHARMACEUTICALS - - 32 -